Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

230
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
230
Obesity01:24

Obesity

1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

208
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
208
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

532
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
532
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

163
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
163
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

220
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
220

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a predictive model for postoperative body mass index and diabetes outcomes after metabolic bariatric surgery: retrospective cohort study.

BJS open·2026
Same author

Decision tree-based prediction of 5-year weight trajectories after bariatric surgery in adolescents and young adults: a retrospective cohort study from France and Sweden.

International journal of obesity (2005)·2026
Same author

Associations of PYY, GLP-1 and LEAP2 with changes in feeding-related cognition, body weight and glucose homeostasis after bariatric surgery in non-diabetic women.

Journal of neuroendocrinology·2026
Same author

Underdiagnosed and Undertreated: Obesity and Its Cardiometabolic Burden in Swedish Clinical Practice-Insights From the AROS Database.

Diabetes, obesity & metabolism·2026
Same author

Sleeve gastrectomy versus Roux-en-Y-gastric bypass in patients with body mass index over 50 kg/m2: international multicentre cohort.

BJS open·2026
Same author

Reversal of Roux-en-Y Gastric Bypass: A Swedish National Cohort Study.

Annals of surgery·2026
Same journal

[Parents advice to staff caring for children with cancer].

Lakartidningen·2026
Same journal

[Access to health data for research].

Lakartidningen·2026
Same journal

[CANVAS and RFC1-related disease - a broad clinical spectrum from cough and neuropathy to cerebellar ataxia].

Lakartidningen·2026
Same journal

[Choosing wisely in Swedish neuroradiology].

Lakartidningen·2026
Same journal

[Asthma among athletes - prevalence, diagnosis and treatment].

Lakartidningen·2026
Same journal

[Minimally invasive surgery for colorectal cancer was introduced in a safe and well controlled manner].

Lakartidningen·2026
See all related articles

Related Experiment Video

Updated: Jan 12, 2026

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

12.6K

[Obesity surgery - big benefits with small risks].

Magnus Sundbom1, Niclas Abrahamsson2, Erik Stenberg3

  • 1professor, överläkare, kirurgi, Akademiska sjukhuset, Uppsala; institutionen för kir-urgiska vetenskaper, Uppsala universitet.

Lakartidningen
|November 7, 2025
PubMed
Summary
This summary is machine-generated.

Metabolic and bariatric surgery offers lasting weight loss and improved quality of life for individuals with advanced obesity. Lifelong monitoring and nutritional supplements are essential for sustained success after these procedures.

More Related Videos

Sleeve Gastrectomy in Mice using Surgical Clips
05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

7.3K
One-anastomosis Gastric Bypass OAGB in Rats
08:16

One-anastomosis Gastric Bypass OAGB in Rats

Published on: November 10, 2018

11.4K

Related Experiment Videos

Last Updated: Jan 12, 2026

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

12.6K
Sleeve Gastrectomy in Mice using Surgical Clips
05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

7.3K
One-anastomosis Gastric Bypass OAGB in Rats
08:16

One-anastomosis Gastric Bypass OAGB in Rats

Published on: November 10, 2018

11.4K

Area of Science:

  • Bariatric and Metabolic Surgery
  • Obesity Management
  • Surgical Gastroenterology

Background:

  • Metabolic and bariatric surgery (MBS) aims for long-term weight loss and improved quality of life in patients with obesity.
  • The goal is to enable patients to eat normally without gastrointestinal issues or nutritional deficiencies post-surgery.
  • Advanced obesity (BMI ≥35 kg/m2) is increasingly managed with MBS as a first-line treatment for adults.

Purpose of the Study:

  • To evaluate the efficacy and long-term outcomes of metabolic and bariatric surgery.
  • To establish MBS as a primary treatment for severe obesity and related comorbidities.
  • To highlight the importance of patient consultation in selecting the appropriate surgical procedure.

Main Methods:

  • Review of long-term outcomes in patients undergoing MBS.
  • Analysis of the impact of MBS on obesity-related diseases and quality of life.
  • Assessment of current practices and quality of MBS in Sweden.

Main Results:

  • MBS leads to good long-term weight loss and significant improvement in obesity-related diseases.
  • Patients require lifelong nutritional supplements and ongoing monitoring.
  • Gastric bypass is a recommended procedure for type 2 diabetes and BMI ≥35 kg/m2.

Conclusions:

  • Metabolic and bariatric surgery is an effective first-line treatment for advanced obesity.
  • Lifelong adherence to nutritional supplements and monitoring is crucial for sustained success.
  • Swedish MBS is well-developed, delivering high-quality care and positive long-term results.